0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Helicobacter Pylori Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-10C2535
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Helicobacter Pylori Diagnostics Market Insights and Forecast to 2028
BUY CHAPTERS

Helicobacter Pylori Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-10C2535
Report
March 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Helicobacter Pylori Diagnostics - Market Size

The global market for Helicobacter Pylori Diagnostics was estimated to be worth US$ 638 million in 2023 and is forecast to a readjusted size of US$ 1050.8 million by 2030 with a CAGR of 7.3% during the forecast period 2024-2030

Helicobacter Pylori Diagnostics - Market

Helicobacter Pylori Diagnostics - Market

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
Global Helicobacter Pylori Diagnostics key players include Sekisui Diagnostics, Medline Industries, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, etc. Global top five manufacturers hold a share about 85%. Europe is the largest market, with a share about 30%, followed by Asia-Pacific and North America, both with a share about 25 percent. In terms of product, Non-invasive Techniques is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospitals and Clinics, followed by Diagnostic Laboratories, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Helicobacter Pylori Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Helicobacter Pylori Diagnostics by region & country, by Type, and by Application.
The Helicobacter Pylori Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Helicobacter Pylori Diagnostics.
Market Segmentation

Scope of Helicobacter Pylori Diagnostics - Market Report

Report Metric Details
Report Name Helicobacter Pylori Diagnostics - Market
Forecasted market size in 2030 US$ 1050.8 million
CAGR 7.3%
Forecasted years 2024 - 2030
Segment by Type:
  • Invasive Techniques
  • Non-invasive Techniques
Segment by Application
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics, Quidel, Halyard Health, Cardinal Health, Beckman Coulter, Agilent Technologies, Coris BioConcept
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Helicobacter Pylori Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Helicobacter Pylori Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Helicobacter Pylori Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Helicobacter Pylori Diagnostics - Market size in 2030?

Ans: The Helicobacter Pylori Diagnostics - Market size in 2030 will be US$ 1050.8 million.

What is the market share of major companies in Helicobacter Pylori Diagnostics - Market?

Ans: Global top five manufacturers hold a share about 85%.

Who are the main players in the Helicobacter Pylori Diagnostics - Market report?

Ans: The main players in the Helicobacter Pylori Diagnostics - Market are Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics, Quidel, Halyard Health, Cardinal Health, Beckman Coulter, Agilent Technologies, Coris BioConcept

What are the Application segmentation covered in the Helicobacter Pylori Diagnostics - Market report?

Ans: The Applications covered in the Helicobacter Pylori Diagnostics - Market report are Hospitals and Clinics, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Helicobacter Pylori Diagnostics - Market report?

Ans: The Types covered in the Helicobacter Pylori Diagnostics - Market report are Invasive Techniques, Non-invasive Techniques

1 Market Overview
1.1 Helicobacter Pylori Diagnostics Product Introduction
1.2 Global Helicobacter Pylori Diagnostics Market Size Forecast
1.3 Helicobacter Pylori Diagnostics Market Trends & Drivers
1.3.1 Helicobacter Pylori Diagnostics Industry Trends
1.3.2 Helicobacter Pylori Diagnostics Market Drivers & Opportunity
1.3.3 Helicobacter Pylori Diagnostics Market Challenges
1.3.4 Helicobacter Pylori Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Helicobacter Pylori Diagnostics Players Revenue Ranking (2023)
2.2 Global Helicobacter Pylori Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Helicobacter Pylori Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Helicobacter Pylori Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Helicobacter Pylori Diagnostics
2.6 Helicobacter Pylori Diagnostics Market Competitive Analysis
2.6.1 Helicobacter Pylori Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Helicobacter Pylori Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Helicobacter Pylori Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Invasive Techniques
3.1.2 Non-invasive Techniques
3.2 Global Helicobacter Pylori Diagnostics Sales Value by Type
3.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Helicobacter Pylori Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Helicobacter Pylori Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Diagnostic Laboratories
4.1.3 Others
4.2 Global Helicobacter Pylori Diagnostics Sales Value by Application
4.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Helicobacter Pylori Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Helicobacter Pylori Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Helicobacter Pylori Diagnostics Sales Value by Region
5.1.1 Global Helicobacter Pylori Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Helicobacter Pylori Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Helicobacter Pylori Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Helicobacter Pylori Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Helicobacter Pylori Diagnostics Sales Value, 2019-2030
5.2.2 North America Helicobacter Pylori Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Helicobacter Pylori Diagnostics Sales Value, 2019-2030
5.3.2 Europe Helicobacter Pylori Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Helicobacter Pylori Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Helicobacter Pylori Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Helicobacter Pylori Diagnostics Sales Value, 2019-2030
5.5.2 South America Helicobacter Pylori Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Helicobacter Pylori Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Helicobacter Pylori Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Helicobacter Pylori Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Helicobacter Pylori Diagnostics Sales Value
6.3 United States
6.3.1 United States Helicobacter Pylori Diagnostics Sales Value, 2019-2030
6.3.2 United States Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Helicobacter Pylori Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Helicobacter Pylori Diagnostics Sales Value, 2019-2030
6.4.2 Europe Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Helicobacter Pylori Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Helicobacter Pylori Diagnostics Sales Value, 2019-2030
6.5.2 China Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Helicobacter Pylori Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Helicobacter Pylori Diagnostics Sales Value, 2019-2030
6.6.2 Japan Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Helicobacter Pylori Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Helicobacter Pylori Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Helicobacter Pylori Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Helicobacter Pylori Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Helicobacter Pylori Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Helicobacter Pylori Diagnostics Sales Value, 2019-2030
6.9.2 India Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Helicobacter Pylori Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sekisui Diagnostics
7.1.1 Sekisui Diagnostics Profile
7.1.2 Sekisui Diagnostics Main Business
7.1.3 Sekisui Diagnostics Helicobacter Pylori Diagnostics Products, Services and Solutions
7.1.4 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Sekisui Diagnostics Recent Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Profile
7.2.2 F. Hoffmann-La Roche Main Business
7.2.3 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Products, Services and Solutions
7.2.4 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 F. Hoffmann-La Roche Recent Developments
7.3 Medline Industries
7.3.1 Medline Industries Profile
7.3.2 Medline Industries Main Business
7.3.3 Medline Industries Helicobacter Pylori Diagnostics Products, Services and Solutions
7.3.4 Medline Industries Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Meridian Bioscience Recent Developments
7.4 Meridian Bioscience
7.4.1 Meridian Bioscience Profile
7.4.2 Meridian Bioscience Main Business
7.4.3 Meridian Bioscience Helicobacter Pylori Diagnostics Products, Services and Solutions
7.4.4 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Meridian Bioscience Recent Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Profile
7.5.2 Bio-Rad Laboratories Main Business
7.5.3 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Products, Services and Solutions
7.5.4 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Bio-Rad Laboratories Recent Developments
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Profile
7.6.2 Thermo Fisher Scientific Main Business
7.6.3 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Products, Services and Solutions
7.6.4 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Thermo Fisher Scientific Recent Developments
7.7 Alpha Laboratories
7.7.1 Alpha Laboratories Profile
7.7.2 Alpha Laboratories Main Business
7.7.3 Alpha Laboratories Helicobacter Pylori Diagnostics Products, Services and Solutions
7.7.4 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 Alpha Laboratories Recent Developments
7.8 EKF Diagnostics
7.8.1 EKF Diagnostics Profile
7.8.2 EKF Diagnostics Main Business
7.8.3 EKF Diagnostics Helicobacter Pylori Diagnostics Products, Services and Solutions
7.8.4 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 EKF Diagnostics Recent Developments
7.9 Quidel
7.9.1 Quidel Profile
7.9.2 Quidel Main Business
7.9.3 Quidel Helicobacter Pylori Diagnostics Products, Services and Solutions
7.9.4 Quidel Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Quidel Recent Developments
7.10 Halyard Health
7.10.1 Halyard Health Profile
7.10.2 Halyard Health Main Business
7.10.3 Halyard Health Helicobacter Pylori Diagnostics Products, Services and Solutions
7.10.4 Halyard Health Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Halyard Health Recent Developments
7.11 Cardinal Health
7.11.1 Cardinal Health Profile
7.11.2 Cardinal Health Main Business
7.11.3 Cardinal Health Helicobacter Pylori Diagnostics Products, Services and Solutions
7.11.4 Cardinal Health Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 Cardinal Health Recent Developments
7.12 Beckman Coulter
7.12.1 Beckman Coulter Profile
7.12.2 Beckman Coulter Main Business
7.12.3 Beckman Coulter Helicobacter Pylori Diagnostics Products, Services and Solutions
7.12.4 Beckman Coulter Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Beckman Coulter Recent Developments
7.13 Agilent Technologies
7.13.1 Agilent Technologies Profile
7.13.2 Agilent Technologies Main Business
7.13.3 Agilent Technologies Helicobacter Pylori Diagnostics Products, Services and Solutions
7.13.4 Agilent Technologies Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.13.5 Agilent Technologies Recent Developments
7.14 Coris BioConcept
7.14.1 Coris BioConcept Profile
7.14.2 Coris BioConcept Main Business
7.14.3 Coris BioConcept Helicobacter Pylori Diagnostics Products, Services and Solutions
7.14.4 Coris BioConcept Helicobacter Pylori Diagnostics Revenue (US$ Million) & (2019-2024)
7.14.5 Coris BioConcept Recent Developments
8 Industry Chain Analysis
8.1 Helicobacter Pylori Diagnostics Industrial Chain
8.2 Helicobacter Pylori Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Helicobacter Pylori Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Helicobacter Pylori Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Helicobacter Pylori Diagnostics Market Trends
    Table 2. Helicobacter Pylori Diagnostics Market Drivers & Opportunity
    Table 3. Helicobacter Pylori Diagnostics Market Challenges
    Table 4. Helicobacter Pylori Diagnostics Market Restraints
    Table 5. Global Helicobacter Pylori Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Helicobacter Pylori Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Helicobacter Pylori Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Helicobacter Pylori Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Helicobacter Pylori Diagnostics
    Table 10. Global Helicobacter Pylori Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Helicobacter Pylori Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Helicobacter Pylori Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Helicobacter Pylori Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Helicobacter Pylori Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Helicobacter Pylori Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Helicobacter Pylori Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Helicobacter Pylori Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Helicobacter Pylori Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Helicobacter Pylori Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Helicobacter Pylori Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Helicobacter Pylori Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Helicobacter Pylori Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Helicobacter Pylori Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Helicobacter Pylori Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Helicobacter Pylori Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Helicobacter Pylori Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Helicobacter Pylori Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Helicobacter Pylori Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Helicobacter Pylori Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Sekisui Diagnostics Basic Information List
    Table 32. Sekisui Diagnostics Description and Business Overview
    Table 33. Sekisui Diagnostics Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Sekisui Diagnostics (2019-2024)
    Table 35. Sekisui Diagnostics Recent Developments
    Table 36. F. Hoffmann-La Roche Basic Information List
    Table 37. F. Hoffmann-La Roche Description and Business Overview
    Table 38. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of F. Hoffmann-La Roche (2019-2024)
    Table 40. F. Hoffmann-La Roche Recent Developments
    Table 41. Medline Industries Basic Information List
    Table 42. Medline Industries Description and Business Overview
    Table 43. Medline Industries Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Medline Industries (2019-2024)
    Table 45. Medline Industries Recent Developments
    Table 46. Meridian Bioscience Basic Information List
    Table 47. Meridian Bioscience Description and Business Overview
    Table 48. Meridian Bioscience Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Meridian Bioscience (2019-2024)
    Table 50. Meridian Bioscience Recent Developments
    Table 51. Bio-Rad Laboratories Basic Information List
    Table 52. Bio-Rad Laboratories Description and Business Overview
    Table 53. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Bio-Rad Laboratories (2019-2024)
    Table 55. Bio-Rad Laboratories Recent Developments
    Table 56. Thermo Fisher Scientific Basic Information List
    Table 57. Thermo Fisher Scientific Description and Business Overview
    Table 58. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Thermo Fisher Scientific (2019-2024)
    Table 60. Thermo Fisher Scientific Recent Developments
    Table 61. Alpha Laboratories Basic Information List
    Table 62. Alpha Laboratories Description and Business Overview
    Table 63. Alpha Laboratories Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Alpha Laboratories (2019-2024)
    Table 65. Alpha Laboratories Recent Developments
    Table 66. EKF Diagnostics Basic Information List
    Table 67. EKF Diagnostics Description and Business Overview
    Table 68. EKF Diagnostics Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of EKF Diagnostics (2019-2024)
    Table 70. EKF Diagnostics Recent Developments
    Table 71. Quidel Basic Information List
    Table 72. Quidel Description and Business Overview
    Table 73. Quidel Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Quidel (2019-2024)
    Table 75. Quidel Recent Developments
    Table 76. Halyard Health Basic Information List
    Table 77. Halyard Health Description and Business Overview
    Table 78. Halyard Health Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Halyard Health (2019-2024)
    Table 80. Halyard Health Recent Developments
    Table 81. Cardinal Health Basic Information List
    Table 82. Cardinal Health Description and Business Overview
    Table 83. Cardinal Health Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Cardinal Health (2019-2024)
    Table 85. Cardinal Health Recent Developments
    Table 86. Beckman Coulter Basic Information List
    Table 87. Beckman Coulter Description and Business Overview
    Table 88. Beckman Coulter Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Beckman Coulter (2019-2024)
    Table 90. Beckman Coulter Recent Developments
    Table 91. Agilent Technologies Basic Information List
    Table 92. Agilent Technologies Description and Business Overview
    Table 93. Agilent Technologies Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Agilent Technologies (2019-2024)
    Table 95. Agilent Technologies Recent Developments
    Table 96. Coris BioConcept Basic Information List
    Table 97. Coris BioConcept Description and Business Overview
    Table 98. Coris BioConcept Helicobacter Pylori Diagnostics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Helicobacter Pylori Diagnostics Business of Coris BioConcept (2019-2024)
    Table 100. Coris BioConcept Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Helicobacter Pylori Diagnostics Downstream Customers
    Table 104. Helicobacter Pylori Diagnostics Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Helicobacter Pylori Diagnostics Product Picture
    Figure 2. Global Helicobacter Pylori Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Helicobacter Pylori Diagnostics Report Years Considered
    Figure 5. Global Helicobacter Pylori Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Helicobacter Pylori Diagnostics Revenue in 2023
    Figure 7. Helicobacter Pylori Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Invasive Techniques Picture
    Figure 9. Non-invasive Techniques Picture
    Figure 10. Global Helicobacter Pylori Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Helicobacter Pylori Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospitals and Clinics
    Figure 13. Product Picture of Diagnostic Laboratories
    Figure 14. Product Picture of Others
    Figure 15. Global Helicobacter Pylori Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Helicobacter Pylori Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Helicobacter Pylori Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Helicobacter Pylori Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Helicobacter Pylori Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Helicobacter Pylori Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Helicobacter Pylori Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Helicobacter Pylori Diagnostics Sales Value (%), (2019-2030)
    Figure 28. United States Helicobacter Pylori Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Helicobacter Pylori Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Helicobacter Pylori Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Helicobacter Pylori Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Helicobacter Pylori Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Helicobacter Pylori Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Helicobacter Pylori Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Helicobacter Pylori Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Helicobacter Pylori Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Helicobacter Pylori Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Helicobacter Pylori Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Helicobacter Pylori Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Helicobacter Pylori Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Helicobacter Pylori Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Helicobacter Pylori Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 49. Helicobacter Pylori Diagnostics Industrial Chain
    Figure 50. Helicobacter Pylori Diagnostics Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Dengue Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26K6048
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ebola Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20L6129
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cytomegalovirus Infection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4F6384
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global IVD Infectious Diseases Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16N6009
Mon Apr 15 00:00:00 UTC 2024

Add to Cart